Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review

Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review

BackgroundThe liver is the second most common site of breast cancer metastasis. Liver directed therapies including hepatic resection, radiofrequency ablation (RFA), transarterial chemo- and radioembolization (TACE/TARE), and hepatic arterial infusion (HAI) have been scarcely researched for breast ca...

Full description

Bibliographic Details
Main Authors:	Kevin Rivera, Dhiresh Rohan Jeyarajah, Kimberly Washington
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Oncology
Subjects:	breast cancer liver metastasis hepatic resection radiofrequency ablation transarterial chemoembolization transarterial radioembolization liver directed therapies
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.643383/full

Similar Items

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
by: Mackenzie Owen, et al.
Published: (2023-04-01)

Progress in Locoregional Interventional Therapy of Primary Hepatocellular Carcinoma
by: ZHOU Shi
Published: (2022-06-01)

Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Stepan M. Esagian, et al.
Published: (2021-06-01)

Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis
by: Yen-Chun Chen, et al.
Published: (2024-01-01)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
by: Tamás Benkö, et al.
Published: (2022-05-01)

Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
by: Shamar Young, et al.
Published: (2023-07-01)

Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures
by: Nils Degrauwe, et al.
Published: (2019-05-01)

Efficacy of selective transarterial chemoembolization for recurred liver metastases from intracranial meningioma: A case report
by: Tomohisa Ishida, MD, PhD, et al.
Published: (2023-09-01)

MODERN METHODS OF LOCAL TREATMENT OF PATIENTS WITH UVEAL MELANOMA WITH LIVER METASTASES
by: L.O. PETROV, et al.
Published: (2022-12-01)

Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis
by: Peng Guo, et al.
Published: (2024-04-01)

Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis
by: Gun Ha Kim, et al.
Published: (2022-05-01)

Multimodal approach to the treatment of hepatocellular carcinoma
by: O G Skipenko, et al.
Published: (2015-09-01)

Invasive methods of hepatocellular carcinoma treatment
by: Gulziya Ismailova, et al.
Published: (2017-12-01)

Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors
by: Cody R. Criss, et al.
Published: (2023-07-01)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
by: Mina S. Makary, et al.
Published: (2020-07-01)

Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01)

Combined versus single locoregional therapy in the treatment of unresectable hepatocellular carcinoma
by: Moustafa H.M. Othman, et al.
Published: (2014-06-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study
by: Yan J, et al.
Published: (2020-04-01)

Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
by: Ah Ran Kim, et al.
Published: (2019-03-01)

Locoregional Approaches in Cholangiocarcinoma Treatment
by: Alexander E. Hare, et al.
Published: (2022-11-01)

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
by: Yuan H, et al.
Published: (2018-11-01)

Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization
by: Julia Wagenpfeil, et al.
Published: (2024-02-01)

Multimodal therapy for hepatocellular carcinoma: A complementary approach to liver transplantation
by: P. Andrew Schumacher, et al.
Published: (2010-01-01)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
by: Tae Hoon Kim, et al.
Published: (2021-09-01)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
by: Amira Isaac, et al.
Published: (2021-11-01)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01)

Microwave ablation combined with transarterial chemoembolization containing doxorubicin hydrochloride liposome for treating primary and metastatic liver cancers
by: Qin Shi, et al.
Published: (2023-08-01)

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
by: Khalid A Jazieh, et al.
Published: (2014-01-01)

Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis
by: Yi‐Ming Liu, et al.
Published: (2023-01-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion
by: Zhenwei Peng, et al.
Published: (2022-12-01)

Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression
by: Shoujin Cao, et al.
Published: (2022-01-01)

Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report
by: Daeun Kim, et al.
Published: (2022-03-01)

Efficacy of Transarterial Chemoembolization on Lesion Reduction in Colorectal Liver Metastases
by: Hossein Ghanaati, et al.
Published: (2012-08-01)

Efficacy of Transarterial Chemoembolization on Lesion Reduction in Colorectal Liver Metastases
by: Hossein Ghanaati, et al.
Published: (2012-08-01)

Retrospective Comparative Study to Assess the Safety and Efficacy of Transradial Arterial Access for Hepatic Tumor Embolizations: A Single Operator Experience
by: Ramanivas Sundareyan, et al.
Published: (2023-01-01)

Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases
by: Audrey Fohlen, et al.
Published: (2023-08-01)

Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy
by: Marwa Ahmed Sakr, et al.
Published: (2021-03-01)

Preoperative Interventional Therapy for Childhood Undifferentiated Embryonal Liver Sarcoma: Two Retrospective Cases from a Single Center
by: Xiaoxia Zhao, et al.
Published: (2015-11-01)